By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Developing treatments for inflammatory diseases, with an initial focus on severe respiratory683K100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
Japan2.37M100.00%